A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

Cadonilimab plus chemotherapy significantly improved progression-free survival in patients with persistent, recurrent, or ...

Rucaparib Maintenance Improves Long-Term Outcomes in Ovarian Cancer Rucaparib maintenance after first-line chemotherapy and ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

HPV, or human papillomavirus, is very common and is spread through sex. Most HPV infections clear up on their own, but ...

Cadonilimab plus platinum-based chemotherapy improved progression-free and overall survival in advanced cervical cancer ...

Cervical cancer is one of the most common cancers among women worldwide, killing hundreds of thousands of people every year.

Cadonilimab plus chemotherapy, with or without bevacizumab, could be a safe and effective treatment option, according to researchers.

Cervical cancer is the fourth most common cancer in women, according to the World Health Organization. In 2022, approximately ...

A new study has revealed that cervical cancer deaths have strongly declined in the U.S. since 2016, likely due to increased ...

The Quad Cancer Moonshot Initiative to fight cervical cancer in the Indo-Pacific region is admirable, but three of the four ...